Login
Toggle navigation
Videos
Categories
Trending
Covergalls: Eco-Friendly High-Visibility Shirt for Women | Alicia Woods, CEO of Covergalls Inc
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Alicia Woods. CEO & Founder of Covergalls Inc.
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
creating something of true significance starts with seeing things|Morgan Beller,General Partner,NFX
00:10:00
A Discussion with Einat Wilf on Israel's Offensive War and the Integrated War Machine of Hamas|Einat Wilf, Professor, Georgetown University
00:10:00
Outcrop Gold' Joe Hebert discusses their Colombian hybrid prospect generation model and the Santa Ana high-grade vein system with a focus on historic data and exploration goals.
00:10:00
Uncovering Investment Opportunities Across Key Sectors
00:10:00
RICHARD ANDREWS President and CEO of CartoCanada Inc
00:10:00
May 2020 Webinar Clip: Sound Financial Planning with Nathan Mersereau | Nathan Mersereau, President, Planning Alternatives Ltd.
00:00:00
Isaac Kohane, MD, PhD Chair of the Department of Biomedical Informatics, Harvard Medical School | Artificial Intelligence and NEJM AI
00:10:00
A Glance Into The Promising Future | Paul West-Sells, President & Ceo, Western Copper And Gold.
00:10:00
Unlock business potential with CMG Cloud, offering scalable solutions, latest software releases, and secure global access to enhance project delivery and productivity.|Pramod Jain is the CEO of Computer Modelling Group
00:10:00
James V. O'Donnell – CEO, American Eagle Outfitters | James V. O'Donnell, CEO , American Eagle Outfitters Inc.
00:10:00
"Navigating UK Equities: Edward Smith and Oliver Jones on Long-Term Investment Strategies" | Edward Smith - Oliver Jones
00:10:00
Investing in Cribl: A $2.45 Billion Data Analytics Startup|Max Gazor,investor,CRV